Beyond GLP-1s: How device therapy could mitigate the obesity epidemic
Episode Description
It’s all about GLP-1s on this week’s episode.
Pharma Editor Lecia Bushak speaks with Fractyl Health CEO Harith Rajagopalan about the company’s prospects in the weight loss space, the recent developments in the GLP-1 arms race and how this will impact marketing around these disease states in the future.
For the Trends segment, we’re continuing the GLP-1 focus with an update on how Eli Lilly is overtaking Novo Nordisk in the diabetes and obesity treatment market.
Check us out at: mmm-online.com
Follow us:
YouTube: @MMM-online
TikTok: @MMMnews
Instagram: @MMMnewsonline
Twitter/X: @MMMnews
LinkedIn: MM+M
To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Music: “Deep Reflection” by DP and Triple Scoop Music.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
